JP2014524888A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014524888A5 JP2014524888A5 JP2014511830A JP2014511830A JP2014524888A5 JP 2014524888 A5 JP2014524888 A5 JP 2014524888A5 JP 2014511830 A JP2014511830 A JP 2014511830A JP 2014511830 A JP2014511830 A JP 2014511830A JP 2014524888 A5 JP2014524888 A5 JP 2014524888A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- alkyl
- substituted
- precatalyst
- disproportionated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- PMJHHCWVYXUKFD-SNAWJCMRSA-N (E)-1,3-pentadiene Chemical compound C\C=C\C=C PMJHHCWVYXUKFD-SNAWJCMRSA-N 0.000 description 1
- 0 C*(C)C(C1N)(*(C2)C1(C(C1N)C(C)=C)C21C1N)C1N Chemical compound C*(C)C(C1N)(*(C2)C1(C(C1N)C(C)=C)C21C1N)C1N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000012041 precatalyst Substances 0.000 description 1
- 150000003303 ruthenium Chemical class 0.000 description 1
- 239000011997 shvo catalyst Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11305634 | 2011-05-23 | ||
| EP11305634.5 | 2011-05-23 | ||
| PCT/EP2012/059344 WO2012160015A1 (en) | 2011-05-23 | 2012-05-21 | Process for the preparation of deuterated compounds containing n-alkyl groups |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014524888A JP2014524888A (ja) | 2014-09-25 |
| JP2014524888A5 true JP2014524888A5 (enExample) | 2015-07-02 |
| JP5925301B2 JP5925301B2 (ja) | 2016-05-25 |
Family
ID=46146876
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014511830A Expired - Fee Related JP5925301B2 (ja) | 2011-05-23 | 2012-05-21 | Ｎ−アルキル基を含有するジュウテリウム化化合物の製造方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9340489B2 (enExample) |
| EP (1) | EP2714624B1 (enExample) |
| JP (1) | JP5925301B2 (enExample) |
| KR (1) | KR20140030267A (enExample) |
| CN (1) | CN103702961A (enExample) |
| CA (1) | CA2834920A1 (enExample) |
| IL (1) | IL229037A0 (enExample) |
| RU (1) | RU2013156864A (enExample) |
| SG (1) | SG194625A1 (enExample) |
| WO (1) | WO2012160015A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015188073A1 (en) | 2014-06-06 | 2015-12-10 | Research Triangle Institute | Apelin receptor (apj) agonists and uses thereof |
| IL308138A (en) * | 2014-11-10 | 2023-12-01 | Evrys Bio Llc | Preparations against human cytomegalovirus and methods of treating it |
| AU2016366310C1 (en) | 2015-12-09 | 2021-09-09 | Research Triangle Institute | Improved apelin receptor (APJ) agonists and uses thereof |
| AU2017325870B2 (en) | 2016-09-16 | 2021-07-22 | Research Traingle Institute | Tetrahydroisoquinoline kappa opioid antagonists |
| ES3032633T3 (en) | 2016-10-12 | 2025-07-22 | Res Triangle Inst | Heterocyclic apelin receptor (apj) agonists and uses thereof |
| JOP20190072A1 (ar) | 2016-10-13 | 2019-04-07 | Glaxosmithkline Ip Dev Ltd | مشتقات 1، 3 سيكلوبوتان ثنائي الاستبدال أو آزيتيدين كمثبطات للإنزيم المخلق للبروستاجلاندين d المكون للدم |
| EP3558996A4 (en) | 2016-12-21 | 2020-08-05 | Research Triangle Institute, International | DIARYLPURINE DERIVATIVES WITH ENHANCED BIOAVAILABILITY |
| US10494316B2 (en) | 2017-04-27 | 2019-12-03 | Deuteria Beverages, Llc | Process for the preparation of deuterated ethanol from D2O |
| AU2018260728B2 (en) * | 2017-04-27 | 2022-07-21 | Deuteria Beverages, Llc | Process for the preparation of deuterated ethanol from D2 |
| AU2018346597B2 (en) | 2017-10-06 | 2023-07-13 | Forma Therapeutics, Inc. | Inhibiting Ubiquitin Specific Peptidase 30 |
| CN109748767A (zh) * | 2017-11-07 | 2019-05-14 | 朱允涛 | 一种利用微波反应装置制备氘代胺类化合物的方法 |
| IL278291B2 (en) | 2018-05-17 | 2023-10-01 | Forma Therapeutics Inc | Condensed bicyclic compounds are useful as ubiquitin-specific peptidase 30 inhibitors |
| BR112021003189A2 (pt) | 2018-08-20 | 2021-05-11 | Duke University | métodos e composições de fármacos para tratar doenças oftálmicas |
| EP4218934B1 (en) | 2018-10-05 | 2025-06-18 | Forma Therapeutics, Inc. | Inhibiting ubiquitin-specific protease 30 (usp30) |
| TWI767148B (zh) | 2018-10-10 | 2022-06-11 | 美商弗瑪治療公司 | 抑制脂肪酸合成酶(fasn) |
| MX2021007437A (es) * | 2018-12-21 | 2021-09-08 | Terran Biosciences Inc | Formas deuteradas y derivados de volinanserina. |
| KR20220054391A (ko) | 2019-08-29 | 2022-05-02 | 리서치 트라이앵글 인스티튜트 | 아펠린 수용체 작용제에 대한 방법 및 용도 |
| WO2021138391A1 (en) | 2019-12-30 | 2021-07-08 | Tyra Biosciences, Inc. | Indazole compounds |
| MX2023007793A (es) | 2020-12-30 | 2023-09-22 | Tyra Biosciences Inc | Compuestos de indazol como inhibidores de cinasas. |
| JP2024507574A (ja) | 2021-02-25 | 2024-02-20 | リサーチ トライアングル インスティテュート | アペリン受容体アゴニストとしてのヘテロアリール誘導体 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4254129A (en) | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
| US5167948A (en) * | 1987-08-07 | 1992-12-01 | Mallinckrodt Medical, Inc. | Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound |
| US5075337A (en) * | 1989-07-26 | 1991-12-24 | G. D. Searle & Co. | Alpha-deuterated 2-alkylaminoacetamide derivatives having reduced toxicity for treatment of CNS disorders |
| WO1991018602A1 (en) | 1990-06-01 | 1991-12-12 | Merrell Dow Pharmaceuticals Inc. | (+)-α-(2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL)ETHYL]-4-PIPERIDINEMETHANOL |
| KR100477070B1 (ko) * | 1994-03-25 | 2006-04-21 | 이소테크니카 인코포레이티드 | 중수소화작용에의한의약품의효능강화법 |
| CA2438318A1 (en) | 2001-02-16 | 2002-08-29 | Aventis Pharmaceuticals Inc. | Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands |
| TW200413273A (en) | 2002-11-15 | 2004-08-01 | Wako Pure Chem Ind Ltd | Heavy hydrogenation method of heterocyclic rings |
| TW200413274A (en) * | 2002-12-27 | 2004-08-01 | Wako Pure Chem Ind Ltd | Deuteration or tritiation method |
| CA2553376A1 (en) * | 2004-01-23 | 2005-08-04 | Wako Pure Chemical Industries, Ltd. | Method of deuteration using mixed catalyst |
| CA2701638A1 (en) * | 2007-04-02 | 2008-10-09 | Concert Pharmaceuticals Inc. | Pharmaceutical calcimimetics |
| WO2009005069A1 (ja) * | 2007-07-05 | 2009-01-08 | Wako Pure Chemical Industries, Ltd. | ルテニウム触媒を用いた重水素化方法 |
| US20100143287A1 (en) * | 2008-12-09 | 2010-06-10 | Auspex Pharmaceuticals, Inc. | Trifluoromethylphenyl modulators of calcium-sensing receptor |
-
2012
- 2012-05-21 SG SG2013079298A patent/SG194625A1/en unknown
- 2012-05-21 US US14/118,705 patent/US9340489B2/en not_active Expired - Fee Related
- 2012-05-21 EP EP12722367.5A patent/EP2714624B1/en not_active Not-in-force
- 2012-05-21 CN CN201280036588.5A patent/CN103702961A/zh active Pending
- 2012-05-21 CA CA2834920A patent/CA2834920A1/en not_active Abandoned
- 2012-05-21 JP JP2014511830A patent/JP5925301B2/ja not_active Expired - Fee Related
- 2012-05-21 WO PCT/EP2012/059344 patent/WO2012160015A1/en not_active Ceased
- 2012-05-21 RU RU2013156864/04A patent/RU2013156864A/ru not_active Application Discontinuation
- 2012-05-21 KR KR1020137034057A patent/KR20140030267A/ko not_active Withdrawn
-
2013
- 2013-10-23 IL IL229037A patent/IL229037A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013040159A5 (ja) | 有機金属錯体 | |
| JP2013147496A5 (ja) | 有機金属錯体 | |
| JP2014029971A5 (ja) | 有機化合物 | |
| JP2013102146A5 (ja) | 化合物 | |
| JP2015042636A5 (ja) | 有機化合物 | |
| JP2013010752A5 (ja) | 有機金属錯体 | |
| JP2012140458A5 (enExample) | ||
| JP2012149030A5 (ja) | 化合物 | |
| JP2013126982A5 (ja) | 有機金属錯体及び発光材料 | |
| JP2012248871A5 (ja) | 発光素子および発光装置 | |
| JP2012092103A5 (enExample) | ||
| JP2010241801A5 (enExample) | ||
| JP2012006912A5 (ja) | トリアゾール誘導体 | |
| JP2015522045A5 (enExample) | ||
| JP2011121940A5 (ja) | 発光素子 | |
| JP2013100341A5 (enExample) | ||
| JP2009535462A5 (enExample) | ||
| JP2010189376A5 (ja) | 有機金属錯体 | |
| JP2013010096A5 (enExample) | ||
| JP2015078176A5 (enExample) | ||
| JP2012107003A5 (ja) | 有機金属錯体 | |
| JP2012140436A5 (ja) | 物質 | |
| JP2013147490A5 (ja) | イリジウム錯体 | |
| JP2013063963A5 (ja) | 複素環化合物 | |
| JP2013010731A5 (ja) | 複素環化合物 |